awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42720284-68CAC376-F473-4593-886D-A192AC146189
Q42720284-68CAC376-F473-4593-886D-A192AC146189
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-68CAC376-F473-4593-886D-A192AC146189
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.
P2093
Q42720284-68CAC376-F473-4593-886D-A192AC146189
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42720284-68CAC376-F473-4593-886D-A192AC146189
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2de794169a8f7bb04f7552c33bb22286fcc60dfa
P1545
12
http://www.w3.org/2001/XMLSchema#string
P2093
Robert C Newton
http://www.w3.org/2001/XMLSchema#string